Department of Biotechnology

New Delhi: The Department of Biotechnology (DBT) has announced that the Omicron-specific mRNA-based Booster vaccine developed using the indigenous platform technology by Gennova Biopharmaceuticals Ltd. and supported under the Mission COVID…

New Delhi: India’s first indigenously developed Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer is all set to launch on Thursday. The vaccine will be launched by the Department of Biotechnology (DBT) in…